W N Kelly

Summary

Affiliation: Mercer University
Country: USA

Publications

  1. ncbi Can the frequency and risks of fatal adverse drug events be determined?
    W N Kelly
    Department of Pharmacy Adminstration, Southern School of Pharmacy, Mercer University, Atlanta, Georgia 30341, USA
    Pharmacotherapy 21:521-7. 2001
  2. ncbi Potential risks and prevention, Part 1: Fatal adverse drug events
    W N Kelly
    Department of Pharmacy Administration, Southern School of Pharmacy, Mercer University, 3001 Mercer University Drive, Atlanta, GA 30341 4155, USA
    Am J Health Syst Pharm 58:1317-24. 2001
  3. ncbi Potential risks and prevention, Part 2: Drug-induced permanent disabilities
    W N Kelly
    Department of Pharmacy Administration, Southern School of Pharmacy, Mercer University, 3001 Mercer University Drive, Atlanta, GA 30341 4155, USA
    Am J Health Syst Pharm 58:1325-9. 2001
  4. ncbi Potential risks and prevention, Part 4: Reports of significant adverse drug events
    W N Kelly
    Department of Pharmacy Administration, Southern School of Pharmacy, Mercer University, 3001 Mercer University Drive, Atlanta, GA, USA
    Am J Health Syst Pharm 58:1406-12. 2001
  5. ncbi The quality of published adverse drug event reports
    William N Kelly
    Department of Administrative and Clinical Sciences, School of Pharmacy, Mercer University, 3001 Mercer University Dr, Atlanta, GA 3034 4155
    Ann Pharmacother 37:1774-8. 2003
  6. ncbi Potential risks and prevention, Part 3: Drug-induced threats to life
    K Marcellino
    Total Therapeutic Management, Kennesaw, GA, USA
    Am J Health Syst Pharm 58:1399-405. 2001
  7. ncbi Risk of myocardial infarction with combination antihypertensive regimens including a dihydropyridine calcium channel blocker in hypertensive diabetics
    Robert J Anderson
    Southern School of Pharmacy, Mercer University, 3001 Mercer University Drive, Atlanta, GA 30341, USA
    J Manag Care Pharm 9:29-35. 2003
  8. ncbi Epidemiology, comparative methods of detection, and preventability of adverse drug events
    Ghada K Al-Tajir
    Drug Information Department, Al Qassimi Hospital, Sharjah, United Arab Emirates
    Ann Pharmacother 39:1169-74. 2005
  9. ncbi Compelling features of a safe medication-use system
    William N Kelly
    William N. Kelly Consulting, Inc, Oldsmar, FL 34677, USA
    Am J Health Syst Pharm 63:1461-8. 2006
  10. ncbi Guidelines for submitting adverse event reports for publication
    William N Kelly
    William N Kelly Consulting, Inc, Oldsmar, Florida 34677, USA
    Pharmacoepidemiol Drug Saf 16:581-7. 2007

Collaborators

Detail Information

Publications11

  1. ncbi Can the frequency and risks of fatal adverse drug events be determined?
    W N Kelly
    Department of Pharmacy Adminstration, Southern School of Pharmacy, Mercer University, Atlanta, Georgia 30341, USA
    Pharmacotherapy 21:521-7. 2001
    ..Potential reasons and risks for fatal adverse drug events, as well as epidemiologic designs for studying this important public health issue, are discussed and issues are raised to promote further thought...
  2. ncbi Potential risks and prevention, Part 1: Fatal adverse drug events
    W N Kelly
    Department of Pharmacy Administration, Southern School of Pharmacy, Mercer University, 3001 Mercer University Drive, Atlanta, GA 30341 4155, USA
    Am J Health Syst Pharm 58:1317-24. 2001
    ..1 million. A review of published case reports of ADEs for 1976-95 yielded information on possible risk factors for fatal ADEs and on which events may have been preventable...
  3. ncbi Potential risks and prevention, Part 2: Drug-induced permanent disabilities
    W N Kelly
    Department of Pharmacy Administration, Southern School of Pharmacy, Mercer University, 3001 Mercer University Drive, Atlanta, GA 30341 4155, USA
    Am J Health Syst Pharm 58:1325-9. 2001
    ..3 million. A review of published case reports of ADEs for 1978-97 yielded information on possible risk factors for drug-induced permanent disabilities and on which events may have been preventable...
  4. ncbi Potential risks and prevention, Part 4: Reports of significant adverse drug events
    W N Kelly
    Department of Pharmacy Administration, Southern School of Pharmacy, Mercer University, 3001 Mercer University Drive, Atlanta, GA, USA
    Am J Health Syst Pharm 58:1406-12. 2001
    ..1 million. A summary analysis of more than 1500 published case reports of ADEs for 1976-97 yielded information on possible risk factors for drug-related deaths, disabilities, and life threats and on which events may have been preventable...
  5. ncbi The quality of published adverse drug event reports
    William N Kelly
    Department of Administrative and Clinical Sciences, School of Pharmacy, Mercer University, 3001 Mercer University Dr, Atlanta, GA 3034 4155
    Ann Pharmacother 37:1774-8. 2003
    ..Case reports of adverse drug events (ADEs) are an important source of information...
  6. ncbi Potential risks and prevention, Part 3: Drug-induced threats to life
    K Marcellino
    Total Therapeutic Management, Kennesaw, GA, USA
    Am J Health Syst Pharm 58:1399-405. 2001
    ..2 million. A review of published case reports of ADEs for 1977-97 yielded information on possible risk factors for drug-induced life threats and on which events may have been preventable...
  7. ncbi Risk of myocardial infarction with combination antihypertensive regimens including a dihydropyridine calcium channel blocker in hypertensive diabetics
    Robert J Anderson
    Southern School of Pharmacy, Mercer University, 3001 Mercer University Drive, Atlanta, GA 30341, USA
    J Manag Care Pharm 9:29-35. 2003
    ....
  8. ncbi Epidemiology, comparative methods of detection, and preventability of adverse drug events
    Ghada K Al-Tajir
    Drug Information Department, Al Qassimi Hospital, Sharjah, United Arab Emirates
    Ann Pharmacother 39:1169-74. 2005
    ..Adverse drug events (ADEs) continue to be of concern to all health professionals. Even serious ADEs are underreported in all patient-care environments...
  9. ncbi Compelling features of a safe medication-use system
    William N Kelly
    William N. Kelly Consulting, Inc, Oldsmar, FL 34677, USA
    Am J Health Syst Pharm 63:1461-8. 2006
  10. ncbi Guidelines for submitting adverse event reports for publication
    William N Kelly
    William N Kelly Consulting, Inc, Oldsmar, Florida 34677, USA
    Pharmacoepidemiol Drug Saf 16:581-7. 2007
    ..They also encourage schools of medicine, pharmacy, and nursing to incorporate them into the relevant curricula that address the detection, evaluation, and reporting of suspected drug or other medical product adverse events...
  11. ncbi Guidelines for submitting adverse event reports for publication
    William N Kelly
    William N Kelly Consulting, Inc, Oldsmar, Florida 34677, USA
    Drug Saf 30:367-73. 2007
    ..They also encourage schools of medicine, pharmacy, and nursing to incorporate them into the relevant curricula that address the detection, evaluation, and reporting of suspected drug or other medical product adverse events...